Negative receptor signalling

Current Opinion in Cell Biology

Volumn 15, Issue 2, 2003, Pages 128-135

  Dikic, Ivan ^a,b   Giordano, Silvia ^c  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^b GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

^c CANDIOLO CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INOSITOL PHOSPHATE; LIGASE; MEMBRANE RECEPTOR; PROTEIN CDC42; PROTEIN TYROSINE KINASE; UBIQUITIN;

APOPTOSIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; ENZYME ACTIVATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION;

EID: 0037376901     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(03)00004-8     Document Type: Review

References (53)

1. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 103:2000;211-225.
2. Hunter T. Protein kinases and phosphatases: the Yin and Yang of protein phosphorylation and signaling. Cell. 80:1995;225-236.
3. Haj F.G., Verveer P.J., Squire A., Neel B.G., Bastiaens P.I. Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum. Science. 295:2002;1708-1711 This manuscript provides images of spatial and temporal interactions between protein tyrosine phosphatase PTP1B and activated epidermal growth factor receptor and platelet-derived growth factor receptor in cells. Following ligand stimulation, receptor tyrosine kinases are internalised in the endosome, where they undergo limited dephosphorylation by PTP1B present on the endoplasmic reticulum.
4. Pickart C.M. Ubiquitin enters the new millennium. Mol. Cell. 8:2001;499-504.
5. Hicke L. Protein regulation by monoubiquitin. Nat. Rev. Mol. Cell. Biol. 2:2001;195-201.
6. Weissman A.M. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell. Biol. 2:2001;169-178.
7. Joazeiro C.A., Weissman A.M. RING finger proteins: mediators of ubiquitin ligase activity. Cell. 102:2000;549-552.
8. Katz M., Shtiegman K., Tal-Or P., Yakir L., Mosesson Y., Harari D., Machluf Y., Asao H., Jovin T., Sugamura K.et al. Ligand-independent degradation of epidermal growth factor receptor involves receptor ubiquitylation and Hgs, an adaptor whose ubiquitin-interacting motif targets ubiquitylation by Nedd4. Traffic. 3:2002;740-751.
9. Xu W., Marcu M., Yuan X., Mimnaugh E., Patterson C., Neckers L. Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu. Proc. Natl. Acad. Sci. U.S.A. 99:2002;12847-12852.
10. Thien C.B., Langdon W.Y. Cbl: many adaptations to regulate protein tyrosine kinases. Nat. Rev. Mol. Cell. Biol. 2:2001;294-307.
11. de Melker A.A., van der Horst G., Calafat J., Jansen H., Borst J. c-Cbl ubiquitinates the EGF receptor at the plasma membrane and remains receptor associated throughout the endocytic route. J. Cell Sci. 114:2001;2167-2178 This article provides convincing evidence that Cbl-mediated ubiquitination of epidermal growth factor receptors (EGFRs) occurs at the plasma membrane, a topic that has been debated for a long time. Cbl and EGFR remain associated along the endosomal compartment and are also co-localised in internal vesicles of multivesicular bodies.
12. Levkowitz G., Waterman H., Zamir E., Kam Z., Oved S., Langdon W.Y., Beguinot L., Geiger B., Yarden Y. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev. 12:1998;3663-3674.
13. Longva K.E., Blystad F.D., Stang E., Larsen A.M., Johannessen L.E., Madshus I.H. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. J. Cell Biol. 156:2002;843-854.
14. ••].
15. ••]) identified a novel function of Cbl in ligand-induced downregulation of receptor tyrosine kinases. Cbl was shown to interact with the CIN85-endophilin complex thus controlling internalisation of epidermal growth factor and c-Met receptors. This pathway was functionally separable from the ubiquitin ligase activity of Cbl and was dependent on direct binding of CIN85 to the evolutionary divergent carboxyl terminus of Cbl.
16. Szymkiewicz I., Kowanetz K., Soubeyran P., Dinarina A., Lipkowitz S., Dikic I. CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases. J. Biol. Chem. 277:2002;39666-39672.
17. Schmidt A., Wolde M., Thiele C., Fest W., Kratzin H., Podtelejnikov A.V., Witke W., Huttner W.B., Soling H.D. Endophilin I mediates synaptic vesicle formation by transfer of arachidonate to lysophosphatidic acid. Nature. 401:1999;133-141.
18. Farsad K., Ringstad N., Takei K., Floyd S.R., Rose K., De Camilli P. Generation of high curvature membranes mediated by direct endophilin bilayer interactions. J. Cell Biol. 155:2001;193-200.
19. •], these results indicate a functional role for monoubiquitination in endosomal sorting of receptor tyrosine kinases and associated protein complexes.
20. Dikic I. CIN85/CMS family of adaptor molecules. FEBS Lett. 529:2002;110.
21. ••].
22. ••]) report the identification 'in silico' and 'in vivo' of a ubiquitin-interaction domain (UIM). UIMs are found usually in endocytic proteins (e.g. Eps15R related, epsins and Hrs) that are also monoubiquitinated after ligand stimulation. The existence of a UIM/ubiquitin-based network involved in regulation of different steps in the endocytic pathway is proposed.
23. Raiborg C., Bache K.G., Gillooly D.J., Madshus I.H., Stang E., Stenmark H. Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early endosomes. Nat. Cell Biol. 4:2002;394-398 The manuscript provides convincing evidence that the ubiquitin-interaction domain of Hrs binds to ubiquitin in vitro and in vivo, and that Hrs sorts ubiquitinated membrane proteins into clathrin-coated microdomains of early endosomes.
24. Katzmann D.J., Babst M., Emr S.D. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell. 106:2001;145-155 This paper identifies the ESCRT (endosomal sorting complex required for transport) multimeric complex able to bind ubiquitinated receptors leading to their invagination into internal vesicles of multivesicular bodies. This broadens our understanding of the molecular machinery involved in sorting of ubiquitinated cargo at the outer membrane of late endosome.
25. Waterman H., Katz M., Rubin C., Shtiegman K., Lavi S., Elson A., Jovin T., Yarden Y. A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling. EMBO J. 21:2002;303-313.
26. Peschard P., Fournier T.M., Lamorte L., Naujokas M.A., Band H., Langdon W.Y., Park M. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol. Cell. 8:2001;995-1004.
27. Yoon C.H., Lee J., Jongeward G.D., Sternberg P.W. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl. Science. 269:1995;1102-1105.
28. De Sepulveda P., Okkenhaug K., Rose J.L., Hawley R.G., Dubreuil P., Rottapel R. Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation. EMBO J. 18:1999;904-915.
29. Casci T., Vinos J., Freeman M. Sprouty, an intracellular inhibitor of Ras signaling. Cell. 96:1999;655-665.
30. Reich A., Sapir A., Shilo B. Sprouty is a general inhibitor of receptor tyrosine kinase signaling. Development. 126:1999;4139-4147.
31. Minowada G., Jarvis L.A., Chi C.L., Neubuser A., Sun X., Hacohen N., Krasnow M.A., Martin G.R. Vertebrate sprouty genes are induced by FGF signaling and can cause chondrodysplasia when overexpressed. Development. 126:1999;4465-4475.
32. Lim J., Yusoff P., Wong E.S., Chandramouli S., Lao D.H., Fong C.W., Guy G.R. The cysteine-rich Sprouty translocation domain targets mitogen-activated protein kinase inhibitory proteins to phosphatidylinositol 4,5-bisphosphate in plasma membranes. Mol. Cell. Biol. 22:2002;7953-7966.
33. Yigzaw Y., Cartin L., Pierre S., Scholich K., Patel T.B. The C terminus of Sprouty is important for modulation of cellular migration and proliferation. J. Biol. Chem. 276:2001;22742-22747.
34. Hanafusa H., Torii S., Yasunaga T., Nishida E. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat. Cell. Biol. 28:2002;28.
35. Yusoff P., Lao D.H., Ong S.H., Wong E.S., Lim J., Lo T.L., Leong H.F., Fong C.W., Guy G.R. Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. J. Biol. Chem. 277:2002;3195-3201.
36. Lee S.H., Schloss D.J., Jarvis L., Krasnow M.A., Swain J.L. Inhibition of angiogenesis by a mouse Sprouty protein. J. Biol. Chem. 276:2001;4128-4133.
37. Sasaki A., Taketomi T., Wakioka T., Kato R., Yoshimura A. Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation. J. Biol. Chem. 276:2001;36804-36808.
38. Wakioka T., Sasaki A., Kato R., Shouda T., Matsumoto A., Miyoshi K., Tsuneoka M., Komiya S., Baron R., Yoshimura A. Spred is a Sprouty-related suppressor of Ras signalling. Nature. 412:2001;647-651.
39. Egan J.E., Hall A.B., Yatsula B.A., Bar-Sagi D. The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins. Proc. Natl. Acad. Sci. U.S.A. 99:2002;6041-6046 This is the first report indicating that Sprouty2 has a dual role in regulating epidermal growth factor receptor (EGFR) signalling. The conserved carboxy-terminal domain can inhibit EGF-induced mitogen-activated protein kinase (MAPK) activation, while the amino-terminal part of Sprouty2 sequesters Cbl and inhibits EGFR ubiquitination and degradation, thus potentiating EGFR signalling via the MAPK pathway.
40. Wong E.S., Fong C.W., Lim J., Yusoff P., Low B.C., Langdon W.Y., Guy G.R. Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling. EMBO J. 21:2002;4796-4808.
41. Wong E.S., Lim J., Low B.C., Chen Q., Guy G.R. Evidence for direct interaction between Sprouty and Cbl. J. Biol. Chem. 276:2001;5866-5875.
42. Hopper N.A., Lee J., Sternberg P.W. ARK-1 inhibits EGFR signaling in C. elegans. Mol. Cell. 6:2000;65-75.
43. Worby C.A., Simonson-Leff N., Clemens J.C., Huddler D. Jr., Muda M., Dixon J.E. Drosophila Ack targets its substrate, the sorting nexin DSH3PX1, to a protein complex involved in axonal guidance. J. Biol. Chem. 277:2002;9422-9428.
44. Teo M., Tan L., Lim L., Manser E. The tyrosine kinase Ack1 associates with clathrin-coated vesicles through a binding motif shared by arrestin and other adaptors. J. Biol. Chem. 276:2001;18392-18398.
45. Cullen P.J., Cozier G.E., Banting G., Mellor H. Modular phosphoinositide-binding domains - their role in signalling and membrane trafficking. Curr. Biol. 11:2001;R882-R893.
46. Suzuki A., de la Pompa J.L., Stambolic V., Elia A.J., Sasaki T., del Barco Barrantes I., Ho A., Wakeham A., Itie A., Khoo W.et al. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8:1998;1169-1178.
47. •]) report the phenotypes of PTEN- and SHIP2-deficient mice, respectively. Their findings emphasise the diverse biological functions of lipid phosphatases in vivo. PTEN is involved in regulation of brain and heart functions, as well as growth inhibition (see earlier work Suzuki et al. [1998] [46]), while SHIP2 is critical for controlling insulin sensitivity.
48. •].
49. Helgason C.D., Damen J.E., Rosten P., Grewal R., Sorensen P., Chappel S.M., Borowski A., Jirik F., Krystal G., Humphries R.K. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 12:1998;1610-1620.
50. •].
51. Cremona O., Di Paolo G., Wenk M.R., Luthi A., Kim W.T., Takei K., Daniell L., Nemoto Y., Shears S.B., Flavell R.A.et al. Essential role of phosphoinositide metabolism in synaptic vesicle recycling. Cell. 99:1999;179-188.
52. Hill E., van Der Kaay J., Downes C.P., Smythe E. The role of dynamin and its binding partners in coated pit invagination and scission. J. Cell Biol. 152:2001;309-323.
53. Sakisaka T., Itoh T., Miura K., Takenawa T. Phosphatidylinositol 4,5-bisphosphate phosphatase regulates the rearrangement of actin filaments. Mol. Cell. Biol. 17:1997;3841-3849.